{"nct_id":"NCT03226899","title":"A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal Impairment","status":"TERMINATED","status_verified_date":"2021-10","start_date":"2017-07-19","start_date_type":"ACTUAL","primary_completion_date":"2019-02-25","primary_completion_date_type":"ACTUAL","completion_date":"2019-02-25","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["IRWD"]}